BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21189391)

  • 1. Familial risks in cancer of unknown primary: tracking the primary sites.
    Hemminki K; Ji J; Sundquist J; Shu X
    J Clin Oncol; 2011 Feb; 29(4):435-40. PubMed ID: 21189391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis.
    Bevier M; Sundquist J; Hemminki K
    Eur J Cancer Prev; 2012 Nov; 21(6):596-601. PubMed ID: 22387673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007.
    Randén M; Rutqvist LE; Johansson H
    Acta Oncol; 2009; 48(6):915-20. PubMed ID: 19363713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
    Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
    Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Location of metastases in cancer of unknown primary are not random and signal familial clustering.
    Hemminki K; Sundquist K; Sundquist J; Hemminki A; Ji J
    Sci Rep; 2016 Mar; 6():22891. PubMed ID: 26956545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial risks for cancer as the basis for evidence-based clinical referral and counseling.
    Hemminki K; Sundquist J; Lorenzo Bermejo J
    Oncologist; 2008 Mar; 13(3):239-47. PubMed ID: 18378534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of cancer of unknown primary among immigrants to Sweden.
    Shu X; Sundquist K; Sundquist J; Hemminki K
    Eur J Cancer Prev; 2012 Jan; 21(1):10-4. PubMed ID: 22044851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden.
    Shu X; Sundquist K; Sundquist J; Hemminki K
    Eur J Cancer Prev; 2012 May; 21(3):281-8. PubMed ID: 21968687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care.
    Luke C; Koczwara B; Karapetis C; Pittman K; Price T; Kotasek D; Beckmann K; Brown MP; Roder D
    Aust N Z J Public Health; 2008 Aug; 32(4):383-9. PubMed ID: 18782405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial association of prostate cancer with other cancers in the Swedish Family-Cancer Database.
    Hemminki K; Chen B
    Prostate; 2005 Oct; 65(2):188-94. PubMed ID: 15948149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial cancer of unknown primary.
    Rassy E; Kattan J; Pavlidis N
    Int J Clin Oncol; 2019 Oct; 24(10):1328-1331. PubMed ID: 31203526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial multiple primary lung cancers: a population-based analysis from Sweden.
    Li X; Hemminki K
    Lung Cancer; 2005 Mar; 47(3):301-7. PubMed ID: 15713513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer of unknown primary site: missing primary or missing biology?
    Pentheroudakis G; Briasoulis E; Pavlidis N
    Oncologist; 2007 Apr; 12(4):418-25. PubMed ID: 17470684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
    Leu M; Reilly M; Czene K
    J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attributable risks of familial cancer from the Family-Cancer Database.
    Hemminki K; Czene K
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1638-44. PubMed ID: 12496055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial Risk in Patients With Carcinoma of Unknown Primary.
    Samadder NJ; Smith KR; Hanson H; Pimentel R; Wong J; Boucher K; Akerley W; Gilcrease G; Ulrich CM; Burt RW; Curtin K
    JAMA Oncol; 2016 Mar; 2(3):340-6. PubMed ID: 26863281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associated cancers in parents and offspring of polycythaemia vera and myelofibrosis patients.
    Hemminki K; Sundquist J; Bermejo JL
    Br J Haematol; 2009 Nov; 147(4):526-30. PubMed ID: 19754924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MET mutations in cancers of unknown primary origin (CUPs).
    Stella GM; Benvenuti S; Gramaglia D; Scarpa A; Tomezzoli A; Cassoni P; Senetta R; Venesio T; Pozzi E; Bardelli A; Comoglio PM
    Hum Mutat; 2011 Jan; 32(1):44-50. PubMed ID: 20949619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family.
    Amundadottir LT; Thorvaldsson S; Gudbjartsson DF; Sulem P; Kristjansson K; Arnason S; Gulcher JR; Bjornsson J; Kong A; Thorsteinsdottir U; Stefansson K
    PLoS Med; 2004 Dec; 1(3):e65. PubMed ID: 15630470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial cancer risks in affected sibships: results from the Swedish family-cancer database.
    Hemminki K; Kyyrönen P
    Genet Epidemiol; 2000 Sep; 19(2):149-59. PubMed ID: 10962475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.